MedPath

Mydriatic-4

Approved
Approval ID

6e11c346-99d6-e440-e053-2991aa0a79b5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 1, 2018

Manufacturers
FDA

Imprimis NJOF, LLC

DUNS: 080431967

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tropicamide - Proparacine - Phenylephrine - Ketorolac

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71384-632
Product Classification
G
Generic Name
Tropicamide - Proparacine - Phenylephrine - Ketorolac
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 1, 2018
FDA Product Classification

INGREDIENTS (4)

TROPICAMIDEActive
Quantity: 10 mg in 1 mL
Code: N0A3Z5XTC6
Classification: ACTIB
PROPARACAINE HYDROCHLORIDEActive
Quantity: 5 mg in 1 mL
Code: U96OL57GOY
Classification: ACTIB
KETOROLAC TROMETHAMINEActive
Quantity: 5 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIB
PHENYLEPHRINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 mL
Code: 04JA59TNSJ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mydriatic-4 - FDA Drug Approval Details